Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Brain Neoplasms
×
Drug Tolerance
×
Clear all
Filters
3
NCT04771897
2024-12-20
KONQUER
Bexion Pharmaceuticals, Inc.
Phase 1
Terminated
10 enrolled